No black box warning on record for Spherusol

As of the latest FDA labeling reviewed, Spherusol (COCCIDIOIDES IMMITIS SPHERULE-DERIVED SKIN TEST ANTIGEN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Spherusol medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Acute hypersensitivity reactions and anaphylaxis have occurred following the administration of other skin test antigens and may occur in individuals following the administration of Spherusol ® . ( 5.1 ) Patients receiving beta-blocking drugs may be refractive to the usual dose of epinephrine in cases of hypersensitivity. ( 5.2 ) Any condition or agent that impairs or att

No black box warning on record for Spherusol

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Acute hypersensitivity reactions and anaphylaxis have occurred following the administration of other skin test antigens and may occur in individuals following the administration of Spherusol ® . ( 5.1 ) Patients receiving beta-blocking drugs may be refractive to the usual dose of epinephrine in cases of hypersensitivity. ( 5.2 ) Any condition or agent that impairs or att

Spherusol Black Box Warning

No black box warning on record for Spherusol

Other warnings & precautions

Spherusol Black Box Warning

No black box warning on record for Spherusol

Other warnings & precautions